Featured Products
-
Ergomed's Risk-Based Quality Management
2/6/2025
Ergomed’s Meticulous Risk-Based Quality Management Approach
As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.
-
Non‑Animal Pyrogen Detection With MAT
1/20/2026
Within the global pharmaceutical and biotech industries, drug and medical device development are on the rise while stricter regulatory and sustainability requirements are being enforced to demonstrate product quality and safety.
-
Strategic Regulatory Consulting & Planning
1/25/2024
Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.
-
Gain Objective Measures And Subjective Measures Of CNS Function
3/28/2025
NeuroCart is a fully self-contained, mobile CNS test battery developed in-house at CHDR, offering the possibility to measure a wide range of CNS effects in a pharmacological context.
-
Electronic Patient Reported Outcomes (ePRO)
9/16/2024
Capture data at the true source: the patient. Improve the patient experience with secure, accessible questionnaires both via email and through the Castor Connect mobile application.
-
Patient Recruitment With A Patient-Centric Approach
7/31/2024
At Avance Clinical, patients are our priority. We meticulously select experienced sites and clinics, alongside patient advocacy groups and communities to ensure optimal patient care and outcomes.
-
Clinical Trial Recruitment Reinvented
12/17/2024
Clinical Site Services (CSSi) is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sites, sponsors and CROs.
-
Patient Travel And Logistics
12/5/2025
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
Sponsors And CROs
1/13/2026
Our aim is to ensure the flawless and successful execution of clinical research, maximizing its impact on both patients and the commercial market.
-
GMO Solutions
6/27/2023
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).